Janus Henderson Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-8,551,019
Closed -$115M 1416
2018
Q4
$115M Buy
8,551,019
+2,658,973
+45% +$44.8M 0.07% 313
2018
Q3
$114M Buy
5,892,046
+506,878
+9% +$10.8M 0.06% 358
2018
Q2
$138M Buy
5,385,168
+1,265,271
+31% +$29.5M 0.08% 302
2018
Q1
$83M Sell
4,119,897
-113,099
-3% -$2.64M 0.05% 419
2017
Q4
$85M Sell
4,232,996
-98,763
-2% -$1.94M 0.05% 406
2017
Q3
$89.7M Sell
4,331,759
-227,413
-5% -$3.85M 0.06% 387
2017
Q2
$67.5M Buy
+4,559,172
New +$76M 0.05% 443

Other funds holding DPLO

Janus Henderson Group's DPLO Position: Q1 2019 in Review

Janus Henderson Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 8,551,019 shares — an estimated $115M sold.

Janus Henderson Group first reported a position in DPLO in Q2 2017 and held it in 7 quarters. The position peaked at $138M in Q2 2018. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • Janus Henderson Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • Janus Henderson Group sold 8,551,019 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $115M.
  • Janus Henderson Group first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2017 and held it in 7 quarters.
  • Janus Henderson Group's DIPLOMAT PHARMACY, INC. position peaked at $138M in Q2 2018.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on Janus Henderson Group's 13F filing for Q1 2019, filed 30 Apr 2019.